<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="osanctum200/PMC6338118/results/search/drugs/results.xml">
  <result pre="Eligible patients were randomized to Pylorest (a three-in-one tablet containing" exact="rabeprazole" post="20 mg, amoxicillin 1 g, and clarithromycin 500 mg)"/>
  <result pre="randomized to Pylorest (a three-in-one tablet containing rabeprazole 20 mg," exact="amoxicillin" post="1 g, and clarithromycin 500 mg) and Syferol-IHP for"/>
  <result pre="three-in-one tablet containing rabeprazole 20 mg, amoxicillin 1 g, and" exact="clarithromycin" post="500 mg) and Syferol-IHP for 2 weeks, followed by"/>
  <result pre="clarithromycin 500 mg) and Syferol-IHP for 2 weeks, followed by" exact="rabeprazole" post="and Syferol-IHP for 2 weeks or Pylorest and placebo"/>
  <result pre="weeks or Pylorest and placebo for 2 weeks, followed by" exact="rabeprazole" post="and placebo for 2 weeks. Repeat endoscopy-guided biopsy and"/>
  <result pre="standard triple therapy consisting of proton pump inhibitors, such as" exact="amoxicillin" post="and clarithromycin, were suboptimal. 6 Also, in a recent"/>
  <result pre="Pylorest (Saga Laboratories, Ahmedabad, India) tablets (a three-in-one tablet containing" exact="rabeprazole" post="20 mg, amoxicillin 1 g, and clarithromycin 500 mg)"/>
  <result pre="Ahmedabad, India) tablets (a three-in-one tablet containing rabeprazole 20 mg," exact="amoxicillin" post="1 g, and clarithromycin 500 mg) two times a"/>
  <result pre="three-in-one tablet containing rabeprazole 20 mg, amoxicillin 1 g, and" exact="clarithromycin" post="500 mg) two times a day (breakfast and dinner)"/>
  <result pre="administered in conjunction with Pylorest tablets (a three-in-one tablet containing" exact="rabeprazole" post="20 mg, amoxicillin 1 g, and clarithromycin 500 mg)"/>
  <result pre="with Pylorest tablets (a three-in-one tablet containing rabeprazole 20 mg," exact="amoxicillin" post="1 g, and clarithromycin 500 mg) two times a"/>
  <result pre="three-in-one tablet containing rabeprazole 20 mg, amoxicillin 1 g, and" exact="clarithromycin" post="500 mg) two times a day (breakfast and dinner)"/>
  <result pre="dinner) for 2 weeks and followed by 20 mg of" exact="rabeprazole" post="administered twice daily for another 2 weeks. Follow-up During"/>
  <result pre="of Syferol-IHP and conventional triple therapy of rabeprazole, amoxicillin, and" exact="clarithromycin" post="significantly reduced the severity of symptoms of PUD and"/>
  <result pre="and different diagnostic tool opportunities. For instance, triple therapy containing" exact="clarithromycin" post="but not metronidazole appears to be the most prescribed"/>
  <result pre="tool opportunities. For instance, triple therapy containing clarithromycin but not" exact="metronidazole" post="appears to be the most prescribed therapy in the"/>
  <result pre="P Thieroff-Ekerdt R Use of a combination formulation of bismuth," exact="metronidazole" post="and tetracycline with omeprazole as a rescue therapy for"/>
  <result pre="R Use of a combination formulation of bismuth, metronidazole and" exact="tetracycline" post="with omeprazole as a rescue therapy for eradication of"/>
  <result pre="of a combination formulation of bismuth, metronidazole and tetracycline with" exact="omeprazole" post="as a rescue therapy for eradication of Helicobacter pylori"/>
 </snippets>
</snippetsTree>
